Dr. Vikas Majithia with a patient with rheumatoid arthritis.

Patients & Families

 

Patients and families can find hope and make an impact on the search for a cure.

 

Learn about current research aiming to improve the lives of these patients living with rheumatic disease with funding from the Rheumatology Research Foundation.

 

Anna Broder, MD, MSc
Albert Einstein College of Medicine


Dr. Broder is studying the effectiveness of hydroxychloroquine in reducing the mortality rate of patients with systemic lupus erythematosus (SLE) who develop end-stage renal disease. Hydroxychloroquine is an antimalarial drug prescribed to less than 30% of these patients. Although the development of end stage renal disease is one of the most common complications of SLE, there are no studies to date on how to improve outcomes or if hydroxychloroquine is effective. Dr. Broder's study will shed light on the treatment, so that rheumatologists can make more informed decisions when treating SLE patients like Ruth.

University of North Carolina Rheumatologist Dr. Teresa Tarrant.

Teresa Tarrant, MD

Dr. Tarrant is studying a new technology that could deliver rheumatoid arthritis medication straight to the affected joints.

Link

Elana Bernstein, MD, MSc

Dr. Bernstein is studying lung transplants for those with autoimmune diseases.

Link

Jarred Younger - 320 x 215

Jarred Younger, PhD

Dr. Younger's study investigates RA fatigue and depression.

Link

Three rheumatologists from the labs at Emory University

Pathways Newsletter

Get the latest news and updates on Foundation-funded research and training.

Click Thru

Link

Volunteer

We need your expertise and passion to make a difference in the search for a cure.

Click Thru

Link

Join the Conversation

Help raise awareness and support others. Share your story on our Facebook page.

Click Thru

Link

Give today and help transform the future for millions of people living with rheumatic disease.